公开(公告)号：US20220252581A1

公开(公告)日：2022-08-11

申请号：US17548314

申请日：2021-12-10

申请人： Huvepharma Inc.

发明人： Ryan L. Vander Veen ,  Mary M. McIlhaney ,  Thomas W. Campi

IPC分类号： G01N33/53 ,  G01N33/543 ,  B01L3/00

摘要： Methods are provided for detecting the presence of monensin in animal feed using a competitive lateral flow assay. The methods allow for qualitative detection of monensin, as well as quantitative detection at a very high level of sensitivity, e.g., detection of 10 ppm or less in a feed sample. Competitive lateral flow assay strip devices are also provided for use in the methods.

公开(公告)号：US20210332322A1

公开(公告)日：2021-10-28

申请号：US17367231

申请日：2021-07-02

申请人： Huvepharma Inc.

发明人： Mary Ann Pfannenstiel ,  Jennifer Albrecht ,  Glen M. Wilkinson

IPC分类号： C12N1/10 ,  A61K39/012 ,  C12N1/04

摘要： Compositions are provided that contain sporulated coccidial oocysts, wherein the compositions are free of antibiotics and comprise formalin at a concentration sufficient to inhibit microbial growth for at least 12 months while maintaining oocyst viability. Methods of preparing such compositions are also provided.

公开(公告)号：US11692164B2

公开(公告)日：2023-07-04

申请号：US17367231

申请日：2021-07-02

申请人： Huvepharma Inc.

发明人： Mary Ann Pfannenstiel ,  Jennifer Albrecht ,  Glen M. Wilkinson

IPC分类号： C12N1/10 ,  C12N1/04 ,  A61K39/012 ,  A61K39/00 ,  A61K35/68

CPC分类号： C12N1/10 ,  A61K39/012 ,  C12N1/04 ,  A61K35/68 ,  A61K2039/51

摘要： Compositions are provided that contain sporulated coccidial oocysts, wherein the compositions are free of antibiotics and comprise formalin at a concentration sufficient to inhibit microbial growth for at least 12 months while maintaining oocyst viability. Methods of preparing such compositions are also provided.

公开(公告)号：US10781418B2

公开(公告)日：2020-09-22

申请号：US16551414

申请日：2019-08-26

申请人： Huvepharma Inc.

发明人： Mary Ann Pfannenstiel ,  Jennifer Albrecht ,  Glen M. Wilkinson

IPC分类号： C12N1/10 ,  A61K39/012 ,  C12N1/04 ,  A61K39/00 ,  A61K35/68

摘要： Compositions are provided that contain sporulated coccidial oocysts, wherein the compositions are free of antibiotics and comprise formalin at a concentration sufficient to inhibit microbial growth for at least 12 months while maintaining oocyst viability. Methods of preparing such compositions are also provided.

公开(公告)号：US11154604B2

公开(公告)日：2021-10-26

申请号：US16267273

申请日：2019-02-04

申请人： HUVEPHARMA, INC.

发明人： Timothy J. Miller ,  Mary Ann Pfannenstiel

IPC分类号： A61K39/395 ,  A61K39/02 ,  A61K39/39 ,  A61K39/00

摘要： The present disclosure provides for an adjuvant composition that is suited for injectable as well as transdermal administration. The adjuvant composition generally comprises a lipophile, a polymer of acrylic or methacrylic acid, saline, cholesterol, a saponin, and sodium hydroxide. A vaccine composition is also provided for that generally includes the vaccine composition of the present disclosure and an antigen. A method for vaccinating animals and humans utilizing the adjuvant composition of the present disclosure is also provided.